ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $229,211 | -77.1% | 7,992 | -80.9% | 0.01% | -78.6% |
| Q1 2023 | $1,000,532 | +188.1% | 41,741 | +103.8% | 0.04% | +133.3% |
| Q4 2022 | $347,307 | -11.6% | 20,478 | -17.9% | 0.02% | +5.9% |
| Q2 2022 | $393,000 | -65.1% | 24,954 | -18.0% | 0.02% | -76.1% |
| Q4 2021 | $1,126,000 | -23.0% | 30,443 | -14.0% | 0.07% | -48.2% |
| Q1 2021 | $1,462,000 | – | 35,400 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |